• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

Article

May 20, 2016

The Link Between Untreated Sleep Apnea and Aggressive Melanoma

Author(s):

Amy Jacob

Researchers examine the relationship between sleep disorders and melanoma.

New research in skin cancer discovered untreated severe obstructive sleep apnea (OSA) could increase the aggressiveness of malignant cutaneous melanoma.

Results from the study on the relationship between sleep-disordered breathing — apnea or hypopnea – and melanoma were presented at the ATS 2016 International Conference in San Francisco, CA.

Miguel Angel Martinez-Garcia, MD, PhD, Hospital Universitario y Politècnico La Fe, Valencia, Spain, and colleagues conducted the study of 412 patients with confirmed cases of cutaneous malignant melanoma to assess several factors demonstrating their prognosis.

This study was a result of earlier animal studies that showed the similar link between melanoma growth and sleep apnea.

All patients were required to undergo sleep studies — patients previously treated with CPAP were excluded.

Results showed patients diagnosed with the most aggressive cancers also experienced higher odds (and severity) of OSA, regardless of age, gender, BMI, skin type, sun exposure, and other melanoma risk factors.

According to Martinez-Garcia, prior research had established an existing connection between sleep apnea, heart disease, and car accidents, and the current study nudges at the potential relationship between sleep apnea and melanoma. However, she urges patients not to immediately assume they, too, would develop skin cancer.

Although further research is necessary, this is the first large, prospective multicenter study that showed “patients had markers of poor prognosis for their melanoma and highlighted the importance of diagnosing and treating sleep apnea.”

The next step would be to observe the same patients for relapse, treatment resistance, development of other cancers or a second melanoma, and mortality.

Similarly, Martinez-Garcia hopes to examine how long-term CPAP therapy could be affecting people with other forms of cancer

In the interim, Martinez-Garcia does urge dermatologists, cancer surgeons, and oncologists to ask their patients if OSA symptoms pose a problem, and if so, refer them for a sleep study.

Related Videos
Pharmacist and patient in a retail/community pharmacy setting -- Image credit: Zamrznuti tonovi | stock.adobe.com
Menoapuse spelled with wooden blocks -- Image credit: loran4a | stock.adobe.com
Related Content
Advertisement
Olaparib box | Image Credit: © luchschenF - stock.adobe.com
May 15th 2025

Gap-Scheduled Olaparib Plus Neoadjuvant Chemotherapy Improved Survival in Patients With gBRCAm TBNC

Alexandra Gerlach, Associate Editor
pharmacy focus oncology edition
May 12th 2025

Insights from a Pharmacy Times Peer Exchange: Emerging ADCs and Real-World Management

Alexandra Gerlach, Associate Editor
CAR T-cell visualization | Image Credit: © Wimon - stock.adobe.com
May 14th 2025

Anitocabtagene Autoleucel Yields Overall Response Rate of 97% in Patients With Multiple Myeloma

Alexandra Gerlach, Associate Editor
Pharmacy Times pharmacy focus oncology edition
May 5th 2025

Novel HER2-low Therapies and Pharmacist-Led ADC Sequencing

Alexandra Gerlach, Associate Editor
Cancer cells, 3D illustration
May 14th 2025

FDA Approves Belzutifan for Treatment of Locally Advanced, Unresectable, or Metastatic Pheochromocytoma and Paraganglioma

Luke Halpern, Assistant Editor
psoriasis is an autoimmune human disease. a man holds a hand at a psoriasis affected area of the skin
May 14th 2025

Icotrokinra Demonstrates Significant Skin Clearance in Difficult-to-Treat Scalp, Genital Psoriasis

Luke Halpern, Assistant Editor
Related Content
Advertisement
Olaparib box | Image Credit: © luchschenF - stock.adobe.com
May 15th 2025

Gap-Scheduled Olaparib Plus Neoadjuvant Chemotherapy Improved Survival in Patients With gBRCAm TBNC

Alexandra Gerlach, Associate Editor
pharmacy focus oncology edition
May 12th 2025

Insights from a Pharmacy Times Peer Exchange: Emerging ADCs and Real-World Management

Alexandra Gerlach, Associate Editor
CAR T-cell visualization | Image Credit: © Wimon - stock.adobe.com
May 14th 2025

Anitocabtagene Autoleucel Yields Overall Response Rate of 97% in Patients With Multiple Myeloma

Alexandra Gerlach, Associate Editor
Pharmacy Times pharmacy focus oncology edition
May 5th 2025

Novel HER2-low Therapies and Pharmacist-Led ADC Sequencing

Alexandra Gerlach, Associate Editor
Cancer cells, 3D illustration
May 14th 2025

FDA Approves Belzutifan for Treatment of Locally Advanced, Unresectable, or Metastatic Pheochromocytoma and Paraganglioma

Luke Halpern, Assistant Editor
psoriasis is an autoimmune human disease. a man holds a hand at a psoriasis affected area of the skin
May 14th 2025

Icotrokinra Demonstrates Significant Skin Clearance in Difficult-to-Treat Scalp, Genital Psoriasis

Luke Halpern, Assistant Editor
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.